Good news — this case cleared the first bar
The AAO withdrew SCOPS' denial, finding the petitioner met three of ten criteria (including original contributions of major significance), and remanded for a final merits determination.
Next step: a full merits review weighing all the evidence together.
A biophysical chemist specializing in NMR spectroscopy and membrane proteins appealed a SCOPS denial of his EB-1A extraordinary ability petition. SCOPS found he met only two of ten criteria (judging and scholarly articles), concluding his original contributions lacked major significance. The AAO reversed on the original contributions criterion, finding SCOPS improperly discounted detailed, corroborated expert letters from independent researchers who explained how his polymer-based nanodiscs revolutionized the study of membrane proteins relevant to diseases like Alzheimer's and cystic fibrosis. With 1,454 citations and commercialized patents corroborating the letters, the AAO found the petitioner met three criteria and remanded the case for a final merits determination.
What worked: Detailed expert letters from independent researchers that specifically described the scientific significance of the petitioner's work — rather than making generic statements — were persuasive. A high citation count (1,454 citations across 45 articles) and evidence of commercialized patents corroborated the expert testimony. The combination of corroborated letters plus objective citation and patent evidence was sufficient to establish original contributions of major significance.
What failed: SCOPS' original finding that the expert letters were insufficient was overturned; no evidence was ultimately found insufficient by the AAO at the threshold stage, though the final merits determination remains pending.
Takeaway: Expert support letters must go beyond generic praise and specifically explain the scientific or practical significance of the petitioner's contributions; pairing such letters with objective corroborating evidence (citation data, patents, commercialization) is critical to meeting the original contributions criterion.
Cases like this are frequently used by attorneys when responding to RFEs or building initial petitions. The evidence patterns that worked (or failed) here directly reflect what USCIS officers look for when evaluating EB-1A criteria.
● Evidence that moved the needle
- Detailed expert letters from independent researchers that specifically described the scientific significance of the petitioner's work — rather than making generic statements — were persuasive
- A high citation count (1,454 citations across 45 articles) and evidence of commercialized patents corroborated the expert testimony
- The combination of corroborated letters plus objective citation and patent evidence was sufficient to establish original contributions of major significance.
● Evidence that wasn't enough alone
- SCOPS' original finding that the expert letters were insufficient was overturned
- no evidence was ultimately found insufficient by the AAO at the threshold stage, though the final merits determination remains pending.
Criterion-by-criterion breakdown
Judging the work of others
MetSCOPS found this criterion met; AAO affirmed. Petitioner peer-reviewed at least 32 articles by other researchers.
Original contributions of major significance
Reversed in their favorSCOPS found this criterion not met; AAO reversed, finding detailed corroborated expert letters, 1,454 citations, and commercialized patents established major significance.
Authorship of scholarly articles
MetSCOPS found this criterion met; AAO affirmed. Petitioner authored 45 peer-reviewed scholarly articles.
Detailed letters from independent expert researchers (including a U.S. university professor of chemistry and biochemistry and a Belgian university professor of chemical biology) specifically explaining the significance of the petitioner's polymer-based nanodisc research
45 peer-reviewed research articles with 1,454 total citations indicating a high citation rate
Three patents and one patent application publication, with evidence of commercialization of patented polymers
Letter from a U.S. university professor of chemical and biochemical engineering who worked with the petitioner during his post-doctoral tenure corroborating the significance of his research
SCOPS found the overall evidence of original contributions insufficient to demonstrate major significance — a finding the AAO reversed
SCOPS improperly discounted detailed, corroborated expert letters explaining the major significance of the petitioner's original contributions to his field.
Completed
I-140 filed
Scientist developing polymer-based nanodiscs for use in nuclear magnetic resonance (NMR) spectroscopy to benefit drug development
Completed
SCOPS — Denied
Initial decision: Denied.
Completed
Appeal to the AAO
Petitioner appealed to the Administrative Appeals Office for de novo review.
2026-03-09
AAO decision — Remanded
The AAO withdrew SCOPS' denial, finding the petitioner met three of ten criteria (including original contributions of major significance), and remanded for a final merits determination.
If you're appealing a similar decision, I-290B must be filed within 30 days of personal service of the denial, or 33 days if mailed.
Find this useful? A coffee helps keep Case Reviewer free and ad-free.
Buy me a coffee